KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Tax Provisions (2016 - 2025)

Charles River Laboratories International has reported Tax Provisions over the past 17 years, most recently at -$17.8 million for Q4 2025.

  • Quarterly results put Tax Provisions at -$17.8 million for Q4 2025, down 485.05% from a year ago — trailing twelve months through Dec 2025 was $42.7 million (down 37.1% YoY), and the annual figure for FY2025 was $42.7 million, down 37.1%.
  • Tax Provisions for Q4 2025 was -$17.8 million at Charles River Laboratories International, down from $31.6 million in the prior quarter.
  • Over the last five years, Tax Provisions for CRL hit a ceiling of $55.8 million in Q4 2022 and a floor of -$17.8 million in Q4 2025.
  • Median Tax Provisions over the past 5 years was $24.2 million (2021), compared with a mean of $21.2 million.
  • Biggest five-year swings in Tax Provisions: soared 559.91% in 2022 and later crashed 485.05% in 2025.
  • Charles River Laboratories International's Tax Provisions stood at $23.8 million in 2021, then soared by 134.37% to $55.8 million in 2022, then crashed by 64.61% to $19.8 million in 2023, then tumbled by 115.41% to -$3.0 million in 2024, then crashed by 485.05% to -$17.8 million in 2025.
  • The last three reported values for Tax Provisions were -$17.8 million (Q4 2025), $31.6 million (Q3 2025), and $18.7 million (Q2 2025) per Business Quant data.